Drugs / ND0801
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01174355 | Oct 2010 → Jun 2017 | attention deficit-hyperactivity disorder | NeuroDerm Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ND0801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01174355 ↗ |
| Action | Activate | “Neuronal acetylcholine receptor protein alpha-7 subunit agonist” CHEMBL3707316 ↗ |
| Target | CHRNA7 | “Neuronal acetylcholine receptor protein alpha-7 subunit agonist” CHEMBL3707316 ↗ |